NUCLEI
We build data portability and data enrichment applications used in financial services for compliance archiving, eDiscovery, and market surveillance use cases. Our customers include some of the worlds largest banks, and our go to market partners include key industry leaders in the Enterprise Information Archiving space.
NUCLEI
Industry:
Financial Services FinTech Information Technology Software
Founded:
2019-01-14
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.nuclei.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Cloudflare Cloudflare Hosting Amazon S3 OpenResty Amazon SSL Amazon CloudFront
Current Employees Featured
Founder
Official Site Inspections
http://www.nuclei.ai
- Host name: server-3-171-38-79.iad61.r.cloudfront.net
- IP address: 3.171.38.79
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Nuclei"
Nuclei
Unlock productivity on Microsoft Teams, Slack, Webex, and Zoom. Effortlessly retain your data.See details»
Nuclei Careers
We democratize access to data, empowering organizations to understand and leverage their data to improve business outcomes while mitigating risks. Join our fully remote team and do the …See details»
Leadership - Nucleai
Leadership Transforming Precision Medicine with AI-powered Pathology Our team’s work is a unique collaboration of experienced AI technologists, physicians and exceptional healthcare research professionals.See details»
Homepage 2024 - Nucleai
Nucleai’s technology stands out by being the first spatial AI tool used by pathologists for clinical trial patient selection that is directly connected to a drug development program. Our platform …See details»
Apps - Identity Management - Okta – Nuclei, Inc.
Jun 30, 2023 · This guide provides an overview of the Okta Identity Management app that facilitates connectivity between Nuclei and Okta. Okta connectivity enhances Nuclei …See details»
Nucleai - Crunchbase Company Profile & Funding
Apr 3, 2018 · Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into …See details»
Nuclei FAQs - Information Security – Nuclei, Inc.
We've built end-to-end automation enabling direct, real-time inspection of Nuclei's information security compliance directly into our infrastructure (AWS), our code, and our organization (HR platform, productivity tools, security training …See details»
Nuclei - Crunchbase Company Profile & Funding
Nuclei unlocks access to the worlds most valuable compliance data. Where is Nuclei's headquarters? Nuclei is located in Holmdel, New Jersey, United States. Who are Nuclei's …See details»
Nuclei Support Resources
The Nuclei Help Center is available 24 hours a day at https://support.nuclei.ai. Email support is available within the Time of Performance and Response Time SLAs outlined below. To open …See details»
Nuclei
The following legal documents relate to Nuclei's products and services.See details»
Nucleai Academy - Nucleai
In this webinar, we will give an overview of why spatial biomarkers are a biological requirement to guide the development of ADCs, bispecifics, and immunotherapy drugs, and how AI algorithms can accurately and reproducibly extract patterns …See details»
Nuclei, AI Spatial Biology Startup, Partners with US-Based Sirona DX
Jul 18, 2022 · Nucleai is developing an artificial intelligence-based precision oncology platform for research and treatment decisions. In March the company announced $33 million in a Series B …See details»
Nuclei Speech Recognition
Nuclei Speech Recognition offers a straightforward and efficient transcription service designed with technical excellence at its core. Our system is built to recognize and transcribe a wide …See details»
Israeli AI precision oncology co Nucleai raises $33m - Globes
Mar 22, 2022 · Israeli AI precision cancer drug treatment company Nucleai today announced that it has completed a $33 million Series B financing round, co-led by Section 32 and Sanofi …See details»
projectdiscovery/nuclei-ai-extension: Nuclei AI - GitHub
Nuclei AI Browser Extension, built on top of cloud.projectdiscovery.io, simplifies the creation of vulnerability templates, by enabling users to extract vulnerability information from any …See details»
AI powered quantification of nuclear morphology in cancers …
Jun 19, 2024 · Here, we describe the development of a pan-tissue, deep learning-based digital pathology pipeline for exhaustive nucleus detection, segmentation, and classification and the …See details»
Nucleai AI-Powered Spatial Biology Platform
Nucleai’s ATOM spatial biology platform leverages computer vision and deep neural networks to structure and characterize tissue and cell architecture in cancer pathology images – helping …See details»
Nuclei Community-powered vulnerability scanning
Nuclei uses a vast templating library to scan applications, cloud infrastructure, and networks to find and remediate vulnerabilities. Packed with features to detect threats across your entire …See details»
Introduction – Nuclei, Inc.
Jul 26, 2022 · The Nuclei API is the primary means for developers to interact with Nuclei applications. API clients can retrieve data directly from Nuclei, and can use that data to extend …See details»
Single-cell transcriptome analysis reveals CD34 as a marker of …
1 day ago · Here we use single-nuclei/cell RNA sequencing of fetal and human pluripotent stem cell-derived sinoatrial node cells to reveal that they consist of three subtypes of pacemaker …See details»